Bremelanotide acetateProduct ingredient for Bremelanotide

Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.⁵ Bremelanotide does not interact with alcohol.² The mechanism by which bremelanotide's action on receptors translates to a clinical effect is still unknown.⁵

Bremelanotide was first described in the literature in 2003 when it was known by the investigational code PT-141.¹ Since then it was investigated for its place in treating sexual dysfunction in men and women but is now only indicated for women.^1,2,5 Other drugs used to treat female sexual dysfunction include flibanserin, estrogen, ospemifene, and prasterone.³

Bremelanotide was granted FDA approval on 21 June 2019.⁵